These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33421712)

  • 21. New isatin derivatives with antioxidant activity.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Cremonini MA; Placucci G; Cervellati R; Greco E
    Eur J Med Chem; 2010 Apr; 45(4):1374-8. PubMed ID: 20060202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
    Nam NH; Huong TL; Dung do TM; Dung PT; Oanh DT; Quyen D; Thao le T; Park SH; Kim KR; Han BW; Yun J; Kang JS; Kim Y; Han SB
    Eur J Med Chem; 2013; 70():477-86. PubMed ID: 24185378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
    Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self [3 + 4] Cycloadditions of Isatin N, N'-Cyclic Azomethine Imine 1,3-Dipole with N-( o-Chloromethyl)aryl Amides.
    Jin Q; Zhang J; Jiang C; Zhang D; Gao M; Hu S
    J Org Chem; 2018 Aug; 83(15):8410-8416. PubMed ID: 29846070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p-TSA.H
    Rajesh Kumar M; Violet Dhayabaran V; Sudhapriya N; Manikandan A; Gideon DA; Annapoorani S
    Bioorg Chem; 2020 Sep; 102():104046. PubMed ID: 32688115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors.
    Melis C; Meleddu R; Angeli A; Distinto S; Bianco G; Capasso C; Cottiglia F; Angius R; Supuran CT; Maccioni E
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):68-73. PubMed ID: 27775452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicomponent Reactions with Isocyanides.
    Dömling A; Ugi I
    Angew Chem Int Ed Engl; 2000 Sep; 39(18):3168-3210. PubMed ID: 11028061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of TMSCN to chiral ketimines derived from isatin. Synthesis of an oxindole-based peptidomimetic and a bioactive spirohydantoin.
    Sacchetti A; Silvani A; Gatti FG; Lesma G; Pilati T; Trucchi B
    Org Biomol Chem; 2011 Aug; 9(15):5515-22. PubMed ID: 21687843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isatin derivatives and their anti-bacterial activities.
    Guo H
    Eur J Med Chem; 2019 Feb; 164():678-688. PubMed ID: 30654239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
    Li X; Wu Y; Wang Y; You Q; Zhang X
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses.
    Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR
    Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brønsted-acid-catalyzed asymmetric multicomponent reactions for the facile synthesis of highly enantioenriched structurally diverse nitrogenous heterocycles.
    Yu J; Shi F; Gong LZ
    Acc Chem Res; 2011 Nov; 44(11):1156-71. PubMed ID: 21800828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors.
    Brandão P; López Ó; Leitzbach L; Stark H; Fernández-Bolaños JG; Burke AJ; Pineiro M
    ACS Med Chem Lett; 2021 Nov; 12(11):1718-1725. PubMed ID: 34795859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, in vitro and in vivo antitumor activity of symmetrical bis-Schiff base derivatives of isatin.
    Liang C; Xia J; Lei D; Li X; Yao Q; Gao J
    Eur J Med Chem; 2014 Mar; 74():742-50. PubMed ID: 24176732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isatin Derivatives and Their Antiviral Properties Against Arboviruses: A Review.
    De Moraes Gomes PAT; Pena LJ; Leite ACL
    Mini Rev Med Chem; 2019; 19(1):56-62. PubMed ID: 29692243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An insight into medicinal chemistry of anticancer quinoxalines.
    Kaushal T; Srivastava G; Sharma A; Singh Negi A
    Bioorg Med Chem; 2019 Jan; 27(1):16-35. PubMed ID: 30502116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery.
    Cheke RS; Patil VM; Firke SD; Ambhore JP; Ansari IA; Patel HM; Shinde SD; Pasupuleti VR; Hassan MI; Adnan M; Kadri A; Snoussi M
    Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advance in oxazole-based medicinal chemistry.
    Zhang HZ; Zhao ZL; Zhou CH
    Eur J Med Chem; 2018 Jan; 144():444-492. PubMed ID: 29288945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of Isatin-derived Heterocycles with Promising Anticancer Activities.
    Banerjee B; Sharma A; Singh A; Kaur M; Priya A
    Curr Top Med Chem; 2024 Aug; ():. PubMed ID: 39129163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.